Skip to content

Clinical trials

Insulin Resistance trials in the United States with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Insulin Resistance Phase: Not applicable Country / region: United States Clear all

535 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20027
200310
20049
200520
200624
200726
200829
200934
201023
201128
201221
201325
201425
201520
201623
201718
201825
201922
202012
202120
202216
202325
202424
202519
202620

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed369
Recruiting58
Terminated32
Unknown status28
Active, not recruiting23
Withdrawn18
Suspended3
Not yet recruiting3
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Massachusetts General Hospital20
Pennington Biomedical Research Center20
University of Michigan15
Washington University School of Medicine14
Stanford University13
University of Alabama at Birmingham13
Mayo Clinic12
Yale University12
University of California, San Francisco11
University of California, Davis9

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Insulin Resistance535
Obesity183
Diabetes Mellitus88
Diabetes Mellitus, Type 277
Metabolic Syndrome72
Overweight44
Glucose Intolerance38
Prediabetic State38
Inflammation37
Diabetes Mellitus, Type 133

Trials

Showing 1 to 25 of 535. Each trial links to its page on Pharma Observatory.

435 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.